RecruitingPhase 3NCT05906758

Ultra-Low Contrast Angiography in AKI

Randomized Controlled Trial of Ultra-Low Contrast Coronary Angiography During Acute Kidney Injury (AKI)

Sponsor

Tulane University

Enrollment

32 participants

Start Date

Sep 5, 2025

Study Type

INTERVENTIONAL

Conditions

Acute Kidney Injury

Summary

The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Angiography for people with acute kidney injury. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAngiography

Coronary angiography with less than 20cc of contrast materials

Locations(2)

Tulane University Medical Center

New Orleans, Louisiana, United States

University Medical Center

New Orleans, Louisiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05906758

Related Trials

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

NCT065359458 locations

Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?

NCT035474141 location

LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery

NCT058794329 locations

UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events

NCT058066452 locations

Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury

NCT072364632 locations